ProQR Therapeutics NV PRQR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/24/24 EDT
2.01UNCH (UNCH)
Volume
36,392
52 week range
1.11 - 3.29
Loading...
  • Open2.02
  • Day High2.04
  • Day Low1.97
  • Prev Close2.01
  • 52 Week High3.29
  • 52 Week High Date01/17/24
  • 52 Week Low1.11
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap163.523M
  • Shares Out81.35M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change1.52

KEY STATS

  • Open2.02
  • Day High2.04
  • Day Low1.97
  • Prev Close2.01
  • 52 Week High3.29
  • 52 Week High Date01/17/24
  • 52 Week Low1.11
  • 52 Week Low Date10/27/23
  • Market Cap163.523M
  • Shares Out81.35M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change1.52

RATIOS/PROFITABILITY

  • EPS (TTM)-0.38
  • P/E (TTM)-5.25
  • Fwd P/E (NTM)-4.16
  • EBITDA (TTM)-31.397M
  • ROE (TTM)-52.61%
  • Revenue (TTM)10.191M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-291.18%
  • Debt To Equity (MRQ)47.68%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ProQR Therapeutics NV

 

Profile

MORE
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of...
Sheila Sponselee
Chief People and Operations Officer
Jurriaan Dekkers
Chief Financial Officer
Rene Beukema
Chief Corporate Development Officer, General Counsel, Member of the Management Board
Address
Zernikedreef 9
Leiden
2333 CK
Netherlands

Top Peers

SYMBOLLASTCHG%CHG
MESO
Mesoblast Ltd
6.22UNCHUNCH
OBIO
Orchestra Biomed Holdings Inc
4.48UNCHUNCH
GBIO
Generation Bio Co
2.99UNCHUNCH
VXRT
Vaxart Inc
0.7097UNCHUNCH
ATOS
Atossa Therapeutics Inc
1.50UNCHUNCH